Immune Gene Signature Delineates a Subclass of Papillary Thyroid Cancer with Unfavorable Clinical Outcomes
- Supplementary File 1:
ZIP-Document (ZIP, 1852 KiB)
-
Externally hosted supplementary file 1
Link: http://no
Description: The following are available online at www.mdpi.com/xxx/s1, Table S1: GSEA of three metagene signatures. Top 20 Gene Ontology terms significantly enriched with gene-level weights of 3 metagene signatures are shown. ES and NES are enrichment score and normalized ES as the output of GSEA, respectively, Table S2: Gene-level weights and metagene factors for GSEA of 3 metagene signatures. For 3 metagene signatures, weights for GSEA and metagene factors for metagene projection are shown. The genes in each metagene signature are sorted in order of the weight values, Table S3: Sequencing information of RNAseq (CMC cohort).
Kim, K.; Jeon, S.; Kim, T.-M.; Jung, C.K. Immune Gene Signature Delineates a Subclass of Papillary Thyroid Cancer with Unfavorable Clinical Outcomes. Cancers 2018, 10, 494. https://doi.org/10.3390/cancers10120494
Kim K, Jeon S, Kim T-M, Jung CK. Immune Gene Signature Delineates a Subclass of Papillary Thyroid Cancer with Unfavorable Clinical Outcomes. Cancers. 2018; 10(12):494. https://doi.org/10.3390/cancers10120494
Chicago/Turabian StyleKim, Kyuryung, Sora Jeon, Tae-Min Kim, and Chan K. Jung. 2018. "Immune Gene Signature Delineates a Subclass of Papillary Thyroid Cancer with Unfavorable Clinical Outcomes" Cancers 10, no. 12: 494. https://doi.org/10.3390/cancers10120494